Prosecution Insights
Last updated: August 18, 2026

Examiner: CHEONG, CHEOM-GIL

Tech Center 1700 • Art Units: 1643 1645 1672 1674 1699 1793

This examiner grants 64% of resolved cases

Performance Statistics

64.0%
Allow Rate
-1.0% vs TC avg
215
Total Applications
+51.7%
Interview Lift
1204
Avg Prosecution Days
Based on 186 resolved cases, 2023–2026

Rejection Statute Breakdown

3.1%
§101 Eligibility
16.1%
§102 Novelty
24.6%
§103 Obviousness
37.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18429870 Cutibacterium Acnes Biomimetic, Prebiotic, Probiotic and Postbiotic Compositions for Treatment of Skin Conditions Non-Final OA Johnson & Johnson Consumer Inc.
16979209 COMPOSITIONS AND METHODS FOR DETECTING MYCOBACTERIUM TUBERCULOSIS Non-Final OA THE JOHNS HOPKINS UNIVERSITY
18033813 PROTEINS FOR THE DETECTION OF SCHISTOSOMA INFECTION Non-Final OA MERCK PATENT GMBH
18150466 ALTERNATIVE SURFACTANTS AS STABILIZERS FOR THERAPEUTIC PROTEIN FORMULATIONS Non-Final OA Hoffmann-La Roche Inc.
18417720 IMMUNOMODULATING COMPOSITION CONTAINING GASSERI Non-Final OA THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18189874 METHODS, DEVICE, KIT AND COMPOSITIONS FOR DETECTING FELINE LUNGWORM Non-Final OA Idexx Laboratories, Inc.
17632270 PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE Non-Final OA GLAXOSMITHKLINE BIOLOGICALS SA
18564618 INDICATOR MOLECULE FOR TOXIGENICITY OF AFLATOXIGENIC FUNGI AND USE THEREOF Final Rejection OIL CROPS RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month